Duong Duc Pham, Ji-Hyang Lee, Hyouk-Soo Kwon, Woo-Jung Song, You Sook Cho, Hyunkyoung Kim, Jae-Woo Kwon, So-Young Park, Sujeong Kim, Gyu Young Hur, Byung Keun Kim, Young-Hee Nam, Min-Suk Yang, Mi-Yeong Kim, Sae-Hoon Kim, Byung-Jae Lee, Taehoon Lee, So Young Park, Min-Hye Kim, Young-Joo Cho, ChanSun Park, Jae-Woo Jung, Han Ki Park, Joo-Hee Kim, Ji-Yong Moon, Ian Adcock, Kian Fan Chung, Tae-Bum Kim
BACKGROUND: Although various monoclonal antibodies have been used as add-on therapy for eosinophilic severe asthma (ESA), no direct head-to-head comparative study has evaluated their efficacy. OBJECTIVE: To compare the efficacy of reslizumab, mepolizumab, and dupilumab in patients with ESA through a multicenter prospective observational study. METHODS: Ninety-six ESA patients who had received one of these biological agents for at least six months were included in the study...
May 31, 2023: Annals of Allergy, Asthma & Immunology